Young adults with diabetes also report lower intention of receiving COVID-19 vaccination compared with those 60 years or older
Insulin Rx Fills Down During the Pandemic
Findings significant for adults, but not pediatric subgroups
Medication Type for T2DM May Affect Severe COVID-19 Outcomes
Premorbid GLP1-RA use, SGLT2i use associated with lower 60-day mortality compared to premorbid DPP4i use
Risk Factors ID’d for COVID-19-Related Death in Diabetes
Risk for COVID-19-related death up in association with male sex, older age, preexisting comorbidities, insulin use
Diabetes Mortality Rates Higher Among Blacks Than Whites
Rate ratios significantly higher in 11 cities; Black-White rate ratio about three times higher in Washington, D.C., than national rate ratio
Mortality Higher for Diabetic Ketoacidosis With COVID-19
Obesity, higher insulin requirements may be associated with higher mortality
Predictors of Death, Discharge ID’d for Diabetes Patients With COVID-19
Younger age, routine metformin therapy, and longer symptom duration on admission positively linked to discharge
Metformin Use for T2DM May Reduce COVID-19 Mortality
Odds of contracting COVID-19, COVID-19-related mortality higher for individuals with diabetes
Hyperglycemia, Hypoglycemia Linked to Poor Outcomes in COVID-19
Admission blood glucose is strong predictor of death among patients admitted directly to the ICU
- Page 1 of 2
- 1
- 2